• Two Phase 3 Trials of Ensifentrine in Safely Treating COPD to Open
  • COPD More Prevalent Than Estimated, With Mortality Linked to Aspergillosis, Review Finds
  • Agreement Reached for Hemp Facility to Support Potential COPD Therapy RespRx
  • Verona’s Ensifentrine Found to Ease Breathlessness, Improve Quality of Life
  • SNG001 Can Safely Improve Lung Function in COPD Patients With Viral Infections, Interim Data Show
  • AstraZeneca’s New Data Shows Breztri Aerosphere Better for All Seasons
  • Low-dose Morphine Improves Health in COPD Patients With Shortness of Breath, Phase 4 Trial Suggests
  • COPD Study: Fortified Whey Protein Beverage Increases Muscle Strength
  • Blood Test for IL-32 May Diagnose COPD, Measure Severity, Study Says
  • New Potential Therapeutic Target – FFA4 Protein – Discovered for COPD
  • Phase 2 Trial Starts Testing Multiple Doses of Ensifentrine in Inhaler Formulation
  • University Given $3.9M to Advance Potential COPD Therapy to Clinical Testing